The FDA has approved Caplyta as adjunctive therapy with antidepressants to treat major depressive disorder in adults, ...
TRICARE coverage is primarily used by active and retired military service members and their eligible family members. This policy update, effective immediately, applies to TRICARE beneficiaries in the ...
Experts say FDA officials and doctors should treat hormone therapy like any other drug that has both benefits and risks, and ...
Among inpatients at an academic center, serial adjunctive ketamine infusions were no more effective at treating major depression than midazolam, according to a randomized clinical trial published in ...
Secretary Robert F. Kennedy Jr. announced Monday the black box warning on women’s estrogen-based products for hormone ...
Medical experts are using board game therapy for the mental and emotional well-being of individuals across all age groups ...
A study published Wednesday reports "significant" disparities in the risk of dementia for lower income and non-white ...
UniQure stock dropped after the FDA sent feedback on the company's pending treatment for Huntington's disease. Read more on ...
Relief Mental Health, a leading provider of innovative mental health treatments, is pleased to announce the grand opening of ...
The FDA has approved a Transcranial Magnetic Stimulation device to treat adolescents with severe depression, offering a ...
Inflammatory bowel disease (IBD) is a crowded drug market with plenty of treatment options across the two forms of the ...
Gardening offers a sensory, rhythmic way to calm the nervous system, lift mood, and retrain the brain, helping us heal anxiety and depression from the ground up.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback